Citation Impact
Citing Papers
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis
2016 StandoutNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Caspase-dependent Alterations of Ca2+ Signaling in the Induction of Apoptosis by Hepatitis B Virus X Protein
2003
Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer
2017
Hallmarks of Cancer: The Next Generation
2011 Standout
Inflammation and EMT: an alliance towards organ fibrosis and cancer progression
2009
Novel Small-Molecule Inhibitors of Hepatitis C Virus Entry Block Viral Spread and Promote Viral Clearance in Cell Culture
2012
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Cell Culture Systems for Hepatitis C Virus
2013
Development of novel therapies for hepatitis C
2010
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Hepatitis C virus—host interactions, replication, and viral assembly
2012
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Role of lipid metabolism in hepatitis C virus assembly and entry
2009
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells
2010 StandoutNobel
TGFβ signalling in context
2012 Standout
Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma
2016
Hepatitis C Virus Is Primed by CD81 Protein for Low pH-dependent Fusion
2011
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2019 StandoutNobel
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Advances in experimental systems to study hepatitis C virus in vitro and in vivo
2015
Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan
2011
Stat3-coordinated Lin-28–let-7–HMGA2 and miR-200–ZEB1 circuits initiate and maintain oncostatin M-driven epithelial–mesenchymal transition
2013
Perspectives on tight junction research
2012
Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus
2016
Differential Expression of Candidate Virus Receptors in Human T Lymphocytes Prone or Resistant to Infection with Patient-Derived Hepatitis C Virus
2013
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Obesity in autoimmune diseases: Not a passive bystander
2014
Adaptive Immunity to the Hepatitis C Virus
2010
A Major Determinant of Cyclophilin Dependence and Cyclosporine Susceptibility of Hepatitis C Virus Identified by a Genetic Approach
2010
Claudin Association with CD81 Defines Hepatitis C Virus Entry
2010
Ras Promotes Transforming Growth Factor-β (TGF-β)-induced Epithelial-Mesenchymal Transition via a Leukotriene B4 Receptor-2-linked Cascade in Mammary Epithelial Cells
2014
Claudins and Other Tight Junction Proteins
2012
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Temporal Analysis of Hepatitis C Virus Cell Entry with Occludin Directed Blocking Antibodies
2013
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
2017 StandoutNobel
EMT: 2016
2016 Standout
Signaling pathway cooperation in TGF-β-induced epithelial–mesenchymal transition
2014
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Differential Regulation of Lipoprotein and Hepatitis C Virus Secretion by Rab1b
2017 StandoutNobel
Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics
2010
Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies
2010
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Idiopathic pulmonary fibrosis
2011 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx
2019 StandoutNobel
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
The galectin lattice at a glance
2015
Mutations within a Conserved Region of the Hepatitis C Virus E2 Glycoprotein That Influence Virus-Receptor Interactions and Sensitivity to Neutralizing Antibodies
2010
The role of neutralizing antibodies in hepatitis C virus infection
2011
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
1995 Standout
Hepatitis C Virus Entry
2013
Recombinant Hepatitis C Virus Envelope Glycoprotein Vaccine Elicits Antibodies Targeting Multiple Epitopes on the Envelope Glycoproteins Associated with Broad Cross-Neutralization
2014 StandoutNobel
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Cell Culture Models for Hepatitis E Virus
2019
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Hepatitis C virus cell entry: role of lipoproteins and cellular receptors
2009
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers
2013 StandoutNobel
Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus
2017 StandoutNobel
Hepatitis C Virus Evasion Mechanisms from Neutralizing Antibodies
2011
Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal Antibodies
2013
Seed Sequence-Matched Controls Reveal Limitations of Small Interfering RNA Knockdown in Functional and Structural Studies of Hepatitis C Virus NS5A-MOBKL1B Interaction
2014 StandoutNobel
Hepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus Internalization
2009
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Neutralizing Antibody Response to Hepatitis C Virus
2011
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
Hepatitis C Virus Induces CD81 and Claudin-1 Endocytosis
2012
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Comprehensive linker-scanning mutagenesis of the hepatitis C virus E1 and E2 envelope glycoproteins reveals new structure–function relationships
2011
Mechanisms of TGFβ-Induced Epithelial–Mesenchymal Transition
2016
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Targeting HCV Entry For Development of Therapeutics
2010
Works of Ignacio Benedicto being referenced
Caveolin‐1 deficiency induces a MEK ‐ ERK 1/2‐Snail‐1‐dependent epithelial–mesenchymal transition and fibrosis during peritoneal dialysis
2014
Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes
2009
Inhibition of Transforming Growth Factor-Activated Kinase 1 (TAK1) Blocks and Reverses Epithelial to Mesenchymal Transition of Mesothelial Cells
2012
Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-κB/Snail1 pathway
2008
Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle
2012
Galectin-4-mediated transcytosis of transferrin receptor
2014
Hepatitis C virus envelope components alter localization of hepatocyte tight junction–associated proteins and promote occludin retention in the endoplasmic reticulum†
2008
Increased Circulating Pro-Inflammatory Cytokines and Th17 Lymphocytes in Hashimoto’s Thyroiditis
2009
The Hepatitis B Virus X Protein Binds to and Activates the NH2-Terminal trans-Activation Domain of Nuclear Factor of Activated T Cells-1
2002
Clathrin Mediates Infectious Hepatitis C Virus Particle Egress
2015
The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and Infection
2009
p38 maintains E-cadherin expression by modulating TAK1–NF-κB during epithelial-to-mesenchymal transition
2010
Apolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C Virus
2015